{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:07Z","timestamp":1786984387548,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31372422"],"award-info":[{"award-number":["31372422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gansu province of China","award":["GNSW-2011-12"],"award-info":[{"award-number":["GNSW-2011-12"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.antiviral.2017.01.023","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T11:30:33Z","timestamp":1486035033000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs"],"prefix":"10.1016","volume":"140","author":[{"given":"Yimei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.01.023_bib1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.174.3.1580","article-title":"Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide","volume":"174","author":"Agadjanyan","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib2","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","article-title":"Vaccine adjuvants revisited","volume":"25","author":"Aguilar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.023_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.mi.22.100168.001221","article-title":"Foot-and-mouth disease","volume":"22","author":"Bachrach","year":"1968","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1413","article-title":"Helping the CD8(+) T-cell response","volume":"4","author":"Bevan","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/298030a0","article-title":"Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence","volume":"298","author":"Bittle","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.01.023_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1702(02)00268-X","article-title":"The history of research in foot-and-mouth disease","volume":"91","author":"Brown","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2017.01.023_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vetmic.2013.11.023","article-title":"Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly (I: C)","volume":"168","author":"Cao","year":"2014","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2012.11.009","article-title":"Poly (I: C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs","volume":"97","author":"Cao","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.01.023_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2008.12.007","article-title":"Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in Guinea pigs","volume":"137","author":"Cao","year":"2009","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.vaccine.2007.12.010","article-title":"CpG motif based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine","volume":"26","author":"Conforti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.023_bib11","doi-asserted-by":"crossref","first-page":"e1000050","DOI":"10.1371\/journal.ppat.1000050","article-title":"Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007","volume":"4","author":"Cottam","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.01.023_bib12","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1128\/JVI.00401-08","article-title":"Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide","volume":"82","author":"Cubillos","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.3008333","article-title":"Protection of cattle against foot-and-mouth disease by a synthetic peptide","volume":"232","author":"DiMarchi","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.01.023_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10529-012-0856-0","article-title":"Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus","volume":"34","author":"Fang","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.antiviral.2017.01.023_bib15","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.179.10.6889","article-title":"Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosome cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming","volume":"179","author":"Hoft","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.20506\/rst.21.3.1356","article-title":"The economics of foot and mouth disease","volume":"21","author":"James","year":"2002","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.antiviral.2017.01.023_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsmb.3096","article-title":"Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design","volume":"22","author":"Kotecha","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(02)00260-5","article-title":"Molecular epidemiology of foot-and-mouth disease virus","volume":"91","author":"Knowles","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2017.01.023_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11259-010-9419-9","article-title":"The efficacy of FMD vaccine reduced non-structural proteins with a mAb against 3B protein","volume":"34","author":"Li","year":"2010","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.antiviral.2017.01.023_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1743-422X-7-215","article-title":"Alternative way to test the efficacy of swine FMD vaccines: measurement of pigs median infected dose (PID50) and regulation of live virus challenge dose","volume":"7","author":"Li","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2017.01.023_bib21","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/eji.1830270931","article-title":"CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants","volume":"27","author":"Lipford","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vetmic.2007.05.017","article-title":"Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals","volume":"125","author":"Lu","year":"2007","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vaccine.2009.08.039","article-title":"Foot and mouth disease virus vaccines","volume":"27","author":"Luis","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.023_bib24","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.02775-06","article-title":"Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons","volume":"81","author":"Moraes","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.vaccine.2005.08.108","article-title":"Interferon-gamma production in\u00a0vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV","volume":"24","author":"Parida","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.023_bib26","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.antiviral.2017.01.023_bib27","first-page":"493","article-title":"A\u00a0simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2017.01.023_bib28","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1016\/S0264-410X(03)00364-5","article-title":"A\u00a0synthetic peptide containing the consensus sequence of the G\u2013H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge","volume":"21","author":"Rodriguez","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.023_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1865-1682.2007.01016.x","article-title":"Planning for the progressive control of foot-and-mouth disease worldwide","volume":"55","author":"Rweyemamu","year":"2008","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.antiviral.2017.01.023_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/CVI.00236-10","article-title":"Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine","volume":"18","author":"Shao","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib31","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/JVI.71.4.2606-2614.1997","article-title":"A\u00a0large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants","volume":"71","author":"Taboga","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.antiviral.2017.01.023_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","article-title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists","volume":"61","author":"Vollmer","year":"2009","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.antiviral.2017.01.023_bib34","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/S0264-410X(02)00148-2","article-title":"Effective synthetic peptide vaccine for foot-and-mouth disease in swine","volume":"20","author":"Wang","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.01.023_bib35","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00705-002-0867-6","article-title":"The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells","volume":"147","author":"Zhang","year":"2002","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00253-014-6129-1","article-title":"Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle","volume":"99","author":"Zhang","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.antiviral.2017.01.023_bib37","doi-asserted-by":"crossref","first-page":"e55228","DOI":"10.1371\/journal.pone.0055228","article-title":"Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.01.023_bib38","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.vaccine.2015.09.055","article-title":"Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine","volume":"33","author":"Zheng","year":"2015","journal-title":"Vaccine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T11:52:37Z","timestamp":1601553157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421630420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"alternative-id":["S016635421630420X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.023","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}